Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominanceCNBC • 05/07/24
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdatePRNewsWire • 04/24/24
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.The Motley Fool • 04/24/24
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024PRNewsWire • 04/17/24
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.Market Watch • 04/16/24